Summary
This 8-K filing by Amgen Inc. (AMGN) on April 28, 2016, primarily serves to announce the company's unaudited financial results for the first quarter ended March 31, 2016. The report highlights the issuance of a press release detailing these results, which include both GAAP and non-GAAP financial measures. Investors should note that the press release provides a more comprehensive overview of Amgen's financial performance and condition for the period. Amgen management utilizes these non-GAAP measures, such as adjusted earnings per share and free cash flow, to offer a clearer view of the company's ongoing operational performance, excluding certain items that may not be indicative of core business trends. The company's reasoning for presenting these adjusted figures is also detailed in the press release, aiming to provide investors with a more insightful understanding of financial health and operational efficiency.
Key Highlights
- 1Amgen Inc. reported its unaudited financial results for the three months ended March 31, 2016, via a press release filed on April 28, 2016.
- 2The company provided both U.S. Generally Accepted Accounting Principles (GAAP) and non-GAAP financial measures in its earnings announcement.
- 3Key non-GAAP measures discussed include adjusted earnings per share, free cash flow, adjusted operating income, and adjusted tax rate.
- 4Amgen's management believes these non-GAAP measures offer useful information to investors for assessing financial condition and operational results.
- 5The press release includes reconciliations of non-GAAP measures to their most directly comparable GAAP financial measures.
- 6The information furnished in this 8-K, specifically the press release, is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934.